LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy

Dysregulation of various cells in the tumor microenvironment (TME) causes immunosuppressive functions and aggressive tumor growth. In combination with immune checkpoint blockade (ICB), epigenetic modification-targeted drugs are emerging as attractive cancer treatments. Lysine-specific demethylase 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamun, M A A, Zhang, Yu, Zhao, Jin-Yuan, Shen, Dan-Dan, Guo, Ting, Zheng, Yi-Chao, Zhao, Li-Juan, Liu, Hong-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391765/
https://www.ncbi.nlm.nih.gov/pubmed/37525190
http://dx.doi.org/10.1186/s12929-023-00952-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391765/
https://www.ncbi.nlm.nih.gov/pubmed/37525190
http://dx.doi.org/10.1186/s12929-023-00952-0

Ejemplares similares